Ascendis Pharma As Stock Pattern Recognition Two Crows
| ASND Stock | USD 222.45 16.35 6.85% |
| Symbol |
Recognition |
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The function generated a total of one valid pattern recognition events for the selected time horizon. Two Crows is a 3-day pattern that warns about a possible future trend reversal for Ascendis Pharma AS.
Ascendis Pharma Technical Analysis Modules
Most technical analysis of Ascendis Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ascendis from various momentum indicators to cycle indicators. When you analyze Ascendis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Ascendis Pharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ascendis Pharma AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ascendis Pharma AS based on widely used predictive technical indicators. In general, we focus on analyzing Ascendis Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ascendis Pharma's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Ascendis Pharma's intrinsic value. In addition to deriving basic predictive indicators for Ascendis Pharma, we also check how macroeconomic factors affect Ascendis Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 0.47 | 0.46 | 0.41 | 0.22 | Days Of Inventory On Hand | 1.7K | 2.4K | 2.8K | 4.4K |
Become your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Macroaxis Index Invested over 40 shares | |
 | Driverless Cars Invested over 30 shares | |
 | Momentum Invested over 50 shares | |
 | Impulse Invested over 200 shares | |
 | Investor Favorites Invested few shares | |
 | Hedge Favorites Invested few shares | |
 | Climate Change Invested over 90 shares | |
 | Technology Invested few shares | |
 | Artificial Intelligence Invested few shares | |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ascendis Pharma AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Will Biotechnology sector continue expanding? Could Ascendis diversify its offerings? Factors like these will boost the valuation of Ascendis Pharma. If investors know Ascendis will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ascendis Pharma data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (4.54) | Revenue Per Share | Quarterly Revenue Growth 2.694 | Return On Assets | Return On Equity |
Understanding Ascendis Pharma AS requires distinguishing between market price and book value, where the latter reflects Ascendis's accounting equity. The concept of intrinsic value—what Ascendis Pharma's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Ascendis Pharma's price substantially above or below its fundamental value.
Understanding that Ascendis Pharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Ascendis Pharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Ascendis Pharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.